CY1106249T1 - Συνθεση υπο τη μορφη πηκτωματος προβλεπομενη ωστε να δεχεται ενα δραστικο παραγοντα σε διαλυση ή εναιωρηση ειδικα για εφαρμογη επι ενος βλεννογονου και μεθοδος παρασκευης - Google Patents
Συνθεση υπο τη μορφη πηκτωματος προβλεπομενη ωστε να δεχεται ενα δραστικο παραγοντα σε διαλυση ή εναιωρηση ειδικα για εφαρμογη επι ενος βλεννογονου και μεθοδος παρασκευηςInfo
- Publication number
- CY1106249T1 CY1106249T1 CY20061101679T CY061101679T CY1106249T1 CY 1106249 T1 CY1106249 T1 CY 1106249T1 CY 20061101679 T CY20061101679 T CY 20061101679T CY 061101679 T CY061101679 T CY 061101679T CY 1106249 T1 CY1106249 T1 CY 1106249T1
- Authority
- CY
- Cyprus
- Prior art keywords
- active agent
- composition
- mucosa
- preparation
- receive
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 210000004877 mucosa Anatomy 0.000 title abstract 2
- 239000000725 suspension Substances 0.000 title abstract 2
- 239000000227 bioadhesive Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000003349 gelling agent Substances 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 230000002441 reversible effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Steroid Compounds (AREA)
Abstract
To αντικείμενο της εφευρέσεως είναι μία σύνθεση υπό τη μορφή πηκτώματος προβλεπόμενη για την αγωγή ενός βλεννογόνου με ένα δραστικό παράγοντα, ειδικά του κολπικού βλεννογόνου, χαρακτηριζόμενη από το ότι περιλαμβάνει σε συνδυασμό: τουλάχιστον ένα θερμικά αναστρέψιμο πηκτωματοποιητή, τουλάχιστον ένα βιοσυγκολλητικό προϊόν και τουλάχιστον ένα δραστικό παράγοντα σε διάλυση ή σε εναιώρηση.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9915763A FR2802097B1 (fr) | 1999-12-14 | 1999-12-14 | Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication |
PCT/FR2000/003533 WO2001043720A1 (fr) | 1999-12-14 | 2000-12-14 | Composition sous forme de gel prevue pour recevoir un principe actif en solution ou en suspension, notamment pour application sur une muqueuse et procede de fabrication |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106249T1 true CY1106249T1 (el) | 2011-06-08 |
Family
ID=9553244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20061101679T CY1106249T1 (el) | 1999-12-14 | 2006-11-16 | Συνθεση υπο τη μορφη πηκτωματος προβλεπομενη ωστε να δεχεται ενα δραστικο παραγοντα σε διαλυση ή εναιωρηση ειδικα για εφαρμογη επι ενος βλεννογονου και μεθοδος παρασκευης |
Country Status (13)
Country | Link |
---|---|
US (1) | US20030091642A1 (el) |
EP (1) | EP1237537B1 (el) |
JP (1) | JP2003516957A (el) |
AT (1) | ATE336987T1 (el) |
AU (1) | AU2525601A (el) |
CA (1) | CA2394416A1 (el) |
CY (1) | CY1106249T1 (el) |
DE (1) | DE60030319T2 (el) |
DK (1) | DK1237537T3 (el) |
ES (1) | ES2270895T3 (el) |
FR (1) | FR2802097B1 (el) |
PT (1) | PT1237537E (el) |
WO (1) | WO2001043720A1 (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20031640A1 (it) | 2003-08-08 | 2005-02-09 | Mipharm S P A | Base per gel bioadesivi. |
MY144021A (en) | 2003-09-19 | 2011-07-29 | Drugtech Corp | Pharmaceutical delivery system |
US20060140990A1 (en) * | 2003-09-19 | 2006-06-29 | Drugtech Corporation | Composition for topical treatment of mixed vaginal infections |
US20060093675A1 (en) * | 2004-10-29 | 2006-05-04 | Mathew Ebmeier | Intravaginal treatment of vaginal infections with metronidazole compositions |
MX2007013631A (es) * | 2005-05-09 | 2008-01-24 | Drugtech Corp | Composiciones farmaceuticas de liberacion modificada. |
CA2635986A1 (en) * | 2006-01-05 | 2007-07-12 | Drugtech Corporation | Composition and method of use thereof |
US10045935B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5252318A (en) * | 1990-06-15 | 1993-10-12 | Allergan, Inc. | Reversible gelation compositions and methods of use |
EP0551626A1 (en) * | 1991-12-19 | 1993-07-21 | LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. | Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation |
JP2533723B2 (ja) * | 1992-12-28 | 1996-09-11 | 東興薬品工業株式会社 | 速乾性ゲルタイプ手指消毒剤 |
ES2078175B1 (es) * | 1993-12-31 | 1996-10-16 | Cusi Lab | Formulacion farmaceutica conteniendo clobetasona y tobramicina y sus aplicaciones. |
US5902110A (en) * | 1995-12-18 | 1999-05-11 | The Block Drug Company | Bone regeneration |
US5869601A (en) * | 1996-04-05 | 1999-02-09 | S. C. Johnson & Son, Inc. | Method of stabilizing the viscosity of a thickened composition |
EP1011609A4 (en) * | 1997-05-09 | 2000-08-16 | Medlogic Global Corp | COMPOSITIONS FOR COSMETIC APPLICATIONS |
US7064114B2 (en) * | 1999-03-19 | 2006-06-20 | Parker Hughes Institute | Gel-microemulsion formulations |
-
1999
- 1999-12-14 FR FR9915763A patent/FR2802097B1/fr not_active Expired - Fee Related
-
2000
- 2000-12-14 ES ES00988913T patent/ES2270895T3/es not_active Expired - Lifetime
- 2000-12-14 AU AU25256/01A patent/AU2525601A/en not_active Abandoned
- 2000-12-14 DE DE60030319T patent/DE60030319T2/de not_active Expired - Lifetime
- 2000-12-14 CA CA002394416A patent/CA2394416A1/fr not_active Abandoned
- 2000-12-14 US US10/149,695 patent/US20030091642A1/en not_active Abandoned
- 2000-12-14 JP JP2001544659A patent/JP2003516957A/ja active Pending
- 2000-12-14 PT PT00988913T patent/PT1237537E/pt unknown
- 2000-12-14 EP EP00988913A patent/EP1237537B1/fr not_active Expired - Lifetime
- 2000-12-14 WO PCT/FR2000/003533 patent/WO2001043720A1/fr active IP Right Grant
- 2000-12-14 DK DK00988913T patent/DK1237537T3/da active
- 2000-12-14 AT AT00988913T patent/ATE336987T1/de active
-
2006
- 2006-11-16 CY CY20061101679T patent/CY1106249T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK1237537T3 (da) | 2006-12-27 |
AU2525601A (en) | 2001-06-25 |
JP2003516957A (ja) | 2003-05-20 |
WO2001043720A1 (fr) | 2001-06-21 |
EP1237537A1 (fr) | 2002-09-11 |
FR2802097B1 (fr) | 2002-12-13 |
DE60030319D1 (de) | 2006-10-05 |
DE60030319T2 (de) | 2007-08-30 |
FR2802097A1 (fr) | 2001-06-15 |
US20030091642A1 (en) | 2003-05-15 |
ATE336987T1 (de) | 2006-09-15 |
CA2394416A1 (fr) | 2001-06-21 |
PT1237537E (pt) | 2007-01-31 |
ES2270895T3 (es) | 2007-04-16 |
EP1237537B1 (fr) | 2006-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106249T1 (el) | Συνθεση υπο τη μορφη πηκτωματος προβλεπομενη ωστε να δεχεται ενα δραστικο παραγοντα σε διαλυση ή εναιωρηση ειδικα για εφαρμογη επι ενος βλεννογονου και μεθοδος παρασκευης | |
CY1117370T1 (el) | Φαρμακευτικη παστιλια με βραδεια απελευθερωσης του δραστικου παραγοντα | |
CY1116023T1 (el) | Μορφες φαρμακευτικης δοσολογιας παρατεταμενης απελευθερωσης με περιγραμματα διαλυτοποιησης ελαχιστοποιημενης εξαρτησης απο το ph | |
DE69828595D1 (de) | Gastrointestinale an der mucosa haftende pharmazeutische zusammensetzung | |
TNSN94035A1 (fr) | Composition veterinaire | |
ATE350030T1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
CY1110906T1 (el) | Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης | |
CY1107711T1 (el) | Υπογλωσσια χορηγηση φαρμακευτικης συνθεσης ως αγωγη εναντι οξεων διαταραχων | |
DE69317444T2 (de) | Antivirale topische pharmazeutische zusammensetzungen | |
NO20021013L (no) | Vandig geldannet blanding som omfatter en blokk-kopolymer inkluderende minst en vannopplöselig blokk og en hydrofob blokk | |
BR9901782A (pt) | Forma para dosagem de nefazodona. | |
PT1212317E (pt) | Derivados de indole e sua utilizacao no tratamento de osteoporose entre outras aplicacoes | |
EE04278B1 (et) | Pantoprasoolmagneesiumdihüdraat, seda sisaldav ravim ja selle kasutamine | |
CY1108548T1 (el) | Βιοπροσκολλητικη γελη βασισμενη σε υδροξυαιθυλοκυτταρινη | |
TR200200716T2 (tr) | Ketiyapin granülleri | |
CY1106227T1 (el) | Συνθεση για τη διευκολυνση του ανθρωπινου τοκετου | |
BR9809117A (pt) | Composição de gel retardado de liberação prolongada, processo de produzir a mesma, formulação farmacêutica,e , processos de tratamento de uma indicação , de uma doença, e de uma inflamação com uma composição de liberação prolongada | |
BR9912275A (pt) | Formulação de bioimplante | |
HUP9701611A2 (hu) | Nagy elektrolittartalmú V/O emulzió, alkalmazása bőrkozmetikai készítményekben, különösen irritáció és/vagy érzékeny bőr kezelésére | |
SE9700934D0 (sv) | New formulation | |
ES2183359T3 (es) | Agente desinfectante de pezones por inmersion. | |
DZ3473A1 (fr) | Formulation pharmaceutique a liberation prolongee independante de la force ionique. | |
HUP0300189A2 (hu) | Lipid hordozó készítmény | |
AR003001A1 (es) | Composicion farmaceutica estimuladora de la osteogenesis. | |
AR023815A1 (es) | Solucion oral de prucalopride |